Systematic review of interventions in early pregnancy among pregnant individuals at risk for hyperglycemia

IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY American Journal of Obstetrics & Gynecology Mfm Pub Date : 2025-01-07 DOI:10.1016/j.ajogmf.2025.101606
Larissa Calancie PhD , Madelin O. Brown , Wooyon A. Choi , Jessica L. Caouette MS, RD , James McCann MNSP , Eunice Y. Nam , Erika F. Werner MD, MS
{"title":"Systematic review of interventions in early pregnancy among pregnant individuals at risk for hyperglycemia","authors":"Larissa Calancie PhD ,&nbsp;Madelin O. Brown ,&nbsp;Wooyon A. Choi ,&nbsp;Jessica L. Caouette MS, RD ,&nbsp;James McCann MNSP ,&nbsp;Eunice Y. Nam ,&nbsp;Erika F. Werner MD, MS","doi":"10.1016/j.ajogmf.2025.101606","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The maternal metabolic environment in early pregnancy can influence fetal growth trajectories. Our objective was to identify interventions initiated in early pregnancy (&lt;20 weeks gestation) in pregnant individuals with risk factors for hyperglycemia and report their impact on primary (neonatal adiposity, small for gestational age, large for gestational age, macrosomia) and secondary outcomes (gestational weight gain, maternal hypertensive disorder, birth injury, NICU admission, preterm delivery, emergency cesarean section).</div></div><div><h3>Data Sources</h3><div>We searched Cochrane Central database, Medline, Embase, CINAHL databases, and clinicaltrials.gov (September 2024) for clinical trials published between 2009 and 2024. Search terms included the key words “early OR during” OR “first trimester OR second trimester” AND “gestation OR pregnancy” OR “prenatal care” AND “insulin resistance” OR “metabolic health” OR “diabet*” OR “body composition” OR “obes*” OR “weight gain” OR “gestational diabetes” OR “hyperglycemia” OR “metabolic syndrome” AND “clinical trial.”</div></div><div><h3>Study eligibility criteria</h3><div>Randomized controlled trials (RCTs) and other trials reporting interventions initiated before 20 weeks gestation in participants with singleton pregnancies at risk for hyperglycemia (overweight and/or obesity, history of type 2 diabetes, and/or history of GDM) that reported at least one primary outcome were included. Studies had to be conducted with humans in high income countries as defined by the World Bank, written in English.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>We used the Downs and Black checklist to evaluate the methodological quality and risk. Data was extracted independently and any questions were resolved through group discussion. Interventions were categorized and synthesized by type.</div></div><div><h3>Results</h3><div>21,924 records were identified and 70 full-text articles met inclusion criteria. 65 articles were RCTs. Eight intervention categories were identified: diet only, physical activity or exercise only, diet and physical activity or exercise combined, lifestyle counseling, supplements, pharmaceuticals, early GDM screening, and mixed interventions. Only 12 studies reported statistically significant effects on primary neonatal outcomes.</div></div><div><h3>Conclusions</h3><div>Interventions initiated in early pregnancy (&lt;20 weeks) among pregnant individuals at risk for hyperglycemia that include one or more of the following strategies can reduce risk of excess neonatal adiposity, macrosomia, large for gestational age and small for gestational age neonates: goal-setting and motivational strategies to improve diet and increase physical activity through individual and group sessions; lifestyle coaching that included behavioral techniques designed to empower participants by fostering autonomy in a supportive environment; structured group exercise classes three times per week; and personalized dietary recommendations.</div></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 3","pages":"Article 101606"},"PeriodicalIF":3.8000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Obstetrics & Gynecology Mfm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589933325000072","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The maternal metabolic environment in early pregnancy can influence fetal growth trajectories. Our objective was to identify interventions initiated in early pregnancy (<20 weeks gestation) in pregnant individuals with risk factors for hyperglycemia and report their impact on primary (neonatal adiposity, small for gestational age, large for gestational age, macrosomia) and secondary outcomes (gestational weight gain, maternal hypertensive disorder, birth injury, NICU admission, preterm delivery, emergency cesarean section).

Data Sources

We searched Cochrane Central database, Medline, Embase, CINAHL databases, and clinicaltrials.gov (September 2024) for clinical trials published between 2009 and 2024. Search terms included the key words “early OR during” OR “first trimester OR second trimester” AND “gestation OR pregnancy” OR “prenatal care” AND “insulin resistance” OR “metabolic health” OR “diabet*” OR “body composition” OR “obes*” OR “weight gain” OR “gestational diabetes” OR “hyperglycemia” OR “metabolic syndrome” AND “clinical trial.”

Study eligibility criteria

Randomized controlled trials (RCTs) and other trials reporting interventions initiated before 20 weeks gestation in participants with singleton pregnancies at risk for hyperglycemia (overweight and/or obesity, history of type 2 diabetes, and/or history of GDM) that reported at least one primary outcome were included. Studies had to be conducted with humans in high income countries as defined by the World Bank, written in English.

Study appraisal and synthesis methods

We used the Downs and Black checklist to evaluate the methodological quality and risk. Data was extracted independently and any questions were resolved through group discussion. Interventions were categorized and synthesized by type.

Results

21,924 records were identified and 70 full-text articles met inclusion criteria. 65 articles were RCTs. Eight intervention categories were identified: diet only, physical activity or exercise only, diet and physical activity or exercise combined, lifestyle counseling, supplements, pharmaceuticals, early GDM screening, and mixed interventions. Only 12 studies reported statistically significant effects on primary neonatal outcomes.

Conclusions

Interventions initiated in early pregnancy (<20 weeks) among pregnant individuals at risk for hyperglycemia that include one or more of the following strategies can reduce risk of excess neonatal adiposity, macrosomia, large for gestational age and small for gestational age neonates: goal-setting and motivational strategies to improve diet and increase physical activity through individual and group sessions; lifestyle coaching that included behavioral techniques designed to empower participants by fostering autonomy in a supportive environment; structured group exercise classes three times per week; and personalized dietary recommendations.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高血糖风险孕妇早期妊娠干预措施的系统评价。
目的:妊娠早期母体代谢环境对胎儿生长轨迹的影响。我们的目的是确定早期妊娠开始的干预措施(数据来源:我们检索了Cochrane Central数据库、Medline、Embase、CINAHL数据库和clinicaltrials.gov(2024年9月),以获取2009年至2024年期间发表的临床试验。搜索关键词包括“早期或期间”或“妊娠早期或妊娠中期”和“妊娠或妊娠”或“产前护理”和“胰岛素抵抗”或“代谢健康”或“糖尿病*”或“身体成分”或“肥胖*”或“体重增加”或“妊娠糖尿病”或“高血糖症”或“代谢综合征”和“临床试验”。研究资格标准:随机对照试验(rct)和其他试验报告在妊娠20周前开始干预的有高血糖(超重和/或肥胖,2型糖尿病史,和/或GDM史)的单胎妊娠参与者报告了至少一个主要结局。研究对象必须是世界银行定义的高收入国家的人,用英语写。研究评估和综合方法:我们使用Downs和Black检查表来评估方法学的质量和风险。数据独立提取,任何问题通过小组讨论解决。干预措施按类型进行分类和综合。结果:共检索到21924条记录,70篇全文文章符合纳入标准。65篇为随机对照试验。确定了八个干预类别:仅饮食、仅体育活动或运动、饮食和体育活动或运动结合、生活方式咨询、补充剂、药物、早期GDM筛查和混合干预。只有12项研究报告了对新生儿初级结局有统计学意义的影响。结论:早期妊娠干预措施(
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.40
自引率
3.20%
发文量
254
审稿时长
40 days
期刊介绍: The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including: Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women. Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health. Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child. Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby. Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.
期刊最新文献
The Role of Incorporating Maternal-Fetal Medicine Physicians onto Labor and Delivery in Reducing Maternal Morbidity. Intrauterine vacuum and balloon tamponade devices have similar rates of postpartum hemorrhage control: a retrospective cohort study. Intravenous calcium during spinal anesthesia in preeclamptic women receiving magnesium therapy. Is it not Time to Propose a Maternal-Fetal Definition of Fetal Growth Restriction specifically Linked to Maternal Vascular Malperfusion of the Placenta. Letter to The Editor in response to "Oxytocin regimen used for induction of labor and pregnancy outcomes".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1